Ranolazine, a partial fatty acid oxidation inhibitor, reduces myocardial infarct size and cardiac troponin T release in the rat.
about
Effects of Ranolazine on Astrocytes and Neurons in Primary CultureRanolazine recruits muscle microvasculature and enhances insulin action in rats.Efficacy and safety of a metabolic modulator drug in chronic stable angina: review of evidence from clinical trials.An increase in the redox state during reperfusion contributes to the cardioprotective effect of GIK solution.Role of Fructose as a Potent Antiarrhythmic and Anti-infarct agent in Isolated Rat Heart.Ranolazine: ion-channel-blocking actions and in vivo electrophysiological effects.Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit.Damage to mitochondrial complex I during cardiac ischemia reperfusion injury is reduced indirectly by anti-anginal drug ranolazine.Ranolazine: new approach for the treatment of stable angina pectoris.Free Fatty acids and postischemic myocardial function.Ranolazine attenuated heightened plasma norepinephrine and B-Type natriuretic peptide-45 in improving cardiac function in rats with chronic ischemic heart failure.Metabolic therapy for the treatment of ischemic heart disease: reality and expectations.Acute administration of natural honey protects isolated heart in normothermic ischemia.Effects of Postconditioning, Preconditioning and Perfusion of L-carnitine During Whole Period of Ischemia/ Reperfusion on Cardiac Hemodynamic Functions and Myocardial Infarction Size in Isolated Rat Heart.Zero flow global ischemia-induced injuries in rat heart are attenuated by natural honey.Ranolazine: an anti-anginal drug with further therapeutic potential.Ranolazine treatment for myocardial infarction? Effects on the development of necrosis, left ventricular function and arrhythmias in experimental models.Effects of Postconditioning, Preconditioning and Perfusion of L-carnitine During Whole Period of Ischemia/ Reperfusion on Cardiac Hemodynamic Functions and Myocardial Infarction Size in Isolated Rat Heart.Ranolazine as an adjunct to cardioplegia: a potential new therapeutic application.The antianginal agent, ranolazine, reduces myocardial infarct size but does not alter anatomic no-reflow or regional myocardial blood flow in ischemia/reperfusion in the rabbit.Studies to investigate the pharmacokinetic interactions between ranolazine and ketoconazole, diltiazem, or simvastatin during combined administration in healthy subjects.Ranolazine protects from doxorubicin-induced oxidative stress and cardiac dysfunction.Effects of Postconditioning with Fructose on Arrhythmias and the Size of Infarct Caused by Global Ischemia and Reperfusion in Isolated Rat Heart.
P2860
Q28550579-A2B7EF48-4C68-43D5-8E8D-D2116C69AFFBQ30456763-6F55BF8B-F9E0-45F9-B807-F2DCBB883FCCQ33151781-D3B0DC92-7A7A-4CCF-9DB3-F9124209C0FDQ34337997-341286CD-C5E5-4EAF-B65A-5A6D928C4F3BQ34515951-EE0655C3-D0DC-4A5A-872F-250ADE4C3563Q34549619-BE96539E-BAF2-4640-9FB0-BB954AFE5315Q34573997-C1A3DAD3-B296-416D-B357-CA47FA0B0693Q35718082-BE1833E6-9A3E-434F-BC2A-7AB1A5F4FB1FQ36266000-FC994813-751E-4E5F-B148-5E10616CD2B1Q36588708-8128158B-D91F-4A58-9241-ED08A700248EQ36841418-911F94F3-7C0C-4068-B168-E6C03F80AC51Q37012951-FBFDEEA7-D83A-4333-B12C-5540F17407D5Q37268263-BBE6753A-25E2-4B5D-9B91-3AD05B86B0A1Q37292077-81B362BC-AFA3-4012-B2F8-A871D33162E1Q37354765-C7065DEE-D3EC-4471-A97F-CDFC26064FB1Q37707393-5B2C735E-A336-4D31-AFCA-7C84ABFFC68BQ38238926-08AA67D2-6211-44F2-85A6-AA075B6F3908Q42916088-237133A1-ECFA-4FB5-88DD-13259B1D937EQ44884410-04BA5E34-13C2-405E-A2A9-DEF24F66D7F8Q46163207-E8A3C0E7-A229-4C5C-9C18-FD84485F5263Q46391221-81D47F01-7EC8-4580-A1C3-41C8E13B9D6FQ46941129-A3C262EB-B833-417A-8331-F47D31A51859Q52578970-AAF87D46-FDCF-4558-A4DB-4AFF3A9EDA62
P2860
Ranolazine, a partial fatty acid oxidation inhibitor, reduces myocardial infarct size and cardiac troponin T release in the rat.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Ranolazine, a partial fatty ac ...... troponin T release in the rat.
@ast
Ranolazine, a partial fatty ac ...... troponin T release in the rat.
@en
Ranolazine, a partial fatty ac ...... troponin T release in the rat.
@nl
type
label
Ranolazine, a partial fatty ac ...... troponin T release in the rat.
@ast
Ranolazine, a partial fatty ac ...... troponin T release in the rat.
@en
Ranolazine, a partial fatty ac ...... troponin T release in the rat.
@nl
prefLabel
Ranolazine, a partial fatty ac ...... troponin T release in the rat.
@ast
Ranolazine, a partial fatty ac ...... troponin T release in the rat.
@en
Ranolazine, a partial fatty ac ...... troponin T release in the rat.
@nl
P2093
P1476
Ranolazine, a partial fatty ac ...... troponin T release in the rat.
@en
P2093
Blackburn B
Thiemermann C
Zacharowski K
P304
P356
10.1016/S0014-2999(01)00920-7
P407
P577
2001-04-01T00:00:00Z